Field-Stable Reagent Formulation and Supply

The contract seeks the development and supply of chemically stable, long-shelf-life reagents designed for nucleic acid synthesis, with a focus on formulations that eliminate the need for cold-chain logistics through lyophilization or advanced stabilization chemistry. These reagents must maintain performance integrity under field conditions, ensuring reliable functionality in variable environmental temperatures and prolonged storage without refrigeration, thereby enabling deployment in resource-limited or austere settings. The requirement emphasizes durability, consistency, and scalability of production to meet operational needs without compromising reaction efficiency or specificity. The contract is classified as a subcontract under NAICS code 325992 and is administered by the Army Medical Resources Acquisition Activity within the Department of Defense. Proposals are due by July 24, 2026, and performance is expected to center in Frederick. The solution must deliver reagents capable of supporting field-deployable diagnostic and therapeutic nucleic acid applications, aligning with military medical objectives that prioritize logistical simplicity, operational readiness, and resilience in challenging environments. No specific set-aside designation is indicated, and the procurement is open to qualified contractors meeting the technical and logistical criteria outlined.